CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...

As healthcare spending continues to rise and regulatory pressure intensifies, companies like CVS Health CVS find themselves ...

Good morning, and thank you all for attending the CVS Health Q4 2024 earnings conference call. My name is Brika, and I will ...

Shares of CVS Health (CVS) surged Wednesday morning after the health insurance and pharmacy giant reported ...

CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings ...

Retail pharmacy chain CVS Health (CVS) is scheduled to announce its results for the fourth quarter of 2024 before the market ...

Adjusted earnings for 2025 will be $5.75 to $6 a share, CVS said, while the average estimate of analysts surveyed by ...

CVS Health (CVS) stock jumps 9% after beating Q4 revenue & earnings forecasts thanks mainly to its Health Care Benefits and ...

CVS Health exceeded Q4 sales estimates with $97.71B revenue. The company projects 2025 revenue above $134B and expects ...

CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance ...

CVS Health (CVS +13%) maintains its glow, gapping higher on better-than-expected earnings and revenue in Q4. The pharmaceutical and health insurance giant also returned to issuing guidance following ...

Diversified healthcare company CVS Health (NYSE:CVS) announced better-than-expected revenue in Q4 CY2024, with sales up 4.2% year on year to $97.71 billion. Its non-GAAP profit of $1.19 per share ...